Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

July 31, 2017

Study Completion Date

August 31, 2017

Conditions

Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaNon-Hodgkin Lymphoma

Interventions

DEVICE

iThermonitor

The device is a continuous temperature monitoring tool for home monitoring of temperature. Participants are asked to use this device for two weeks.

Trial Locations (1)

Amanda Centi, Boston

All Listed Sponsors

collaborator

Dana-Farber Cancer Institute

OTHER

lead

Massachusetts General Hospital

OTHER

NCT02410252 - Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies | Biotech Hunter | Biotech Hunter